APA (7th ed.) Citation

Billing, H., Höcker, B., Fichtner, A., & Tönshoff, B. (2017). Single-nucleotide polymorphism of CYP3A5 impacts the exposure to tacrolimus in pediatric renal transplant recipients: A pharmacogenetic substudy of the TWIST trial. Therapeutic drug monitoring, 39(1), . https://doi.org/10.1097/FTD.0000000000000361

Chicago Style (17th ed.) Citation

Billing, Heiko, Britta Höcker, Alexander Fichtner, and Burkhard Tönshoff. "Single-nucleotide Polymorphism of CYP3A5 Impacts the Exposure to Tacrolimus in Pediatric Renal Transplant Recipients: A Pharmacogenetic Substudy of the TWIST Trial." Therapeutic Drug Monitoring 39, no. 1 (2017). https://doi.org/10.1097/FTD.0000000000000361.

MLA (9th ed.) Citation

Billing, Heiko, et al. "Single-nucleotide Polymorphism of CYP3A5 Impacts the Exposure to Tacrolimus in Pediatric Renal Transplant Recipients: A Pharmacogenetic Substudy of the TWIST Trial." Therapeutic Drug Monitoring, vol. 39, no. 1, 2017, https://doi.org/10.1097/FTD.0000000000000361.